Literature DB >> 27207797

Impairment of dendritic cell functions in patients with adaptor protein-3 complex deficiency.

Alberto Prandini1, Valentina Salvi2, Francesca Colombo1, Daniele Moratto1, Luisa Lorenzi3, William Vermi3, Maria Antonia De Francesco4, Lucia Dora Notarangelo5, Fulvio Porta5, Alessandro Plebani1, Fabio Facchetti2, Silvano Sozzani6, Raffaele Badolato1.   

Abstract

Hermansky-Pudlak syndrome type 2 (HPS2) is a primary immunodeficiency due to adaptor protein-3 (AP-3) complex deficiency. HPS2 patients present neutropenia, partial albinism, and impaired lysosomal vesicles formation in hematopoietic cells. Given the role of dendritic cells (DCs) in the immune response, we studied monocyte-derived DCs (moDCs) and plasmacytoid DCs (pDCs) in two HPS2 siblings. Mature HPS2 moDCs showed impaired expression of CD83 and DC-lysosome-associated membrane protein (LAMP), low levels of MIP1-β/CCL4, MIG/CXCL9, and severe defect of interleukin-12 (IL-12) secretion. DCs in lymph-node biopsies from the same patients showed a diffuse cytoplasm reactivity in a large fraction of DC-LAMP(+) cells, instead of the classical dot-like stain. In addition, analysis of pDC-related functions of blood-circulating mononuclear cells revealed reduced interferon-α secretion in response to herpes simplex virus-1 (HSV-1), whereas granzyme-B induction upon IL-3/IL-10 stimulation was normal. Finally, T-cell costimulatory activity, as measured by mixed lymphocyte reaction assay, was lower in patients, suggesting that function and maturation of DCs is abnormal in patients with HPS2.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27207797     DOI: 10.1182/blood-2015-06-650689

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  The road to lysosome-related organelles: Insights from Hermansky-Pudlak syndrome and other rare diseases.

Authors:  Shanna L Bowman; Jing Bi-Karchin; Linh Le; Michael S Marks
Journal:  Traffic       Date:  2019-06       Impact factor: 6.215

2.  Natural killer cell activity and dysfunction in Hermansky-Pudlak syndrome.

Authors:  Aleksandra Gil-Krzewska; Yousuke Murakami; Giovanna Peruzzi; Kevin J O'Brien; Melissa A Merideth; Andrew R Cullinane; William A Gahl; John E Coligan; Bernadette R Gochuico; Konrad Krzewski
Journal:  Br J Haematol       Date:  2016-10-21       Impact factor: 6.998

3.  BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells.

Authors:  Alexis Combes; Voahirana Camosseto; Prudence N'Guessan; Rafael J Argüello; Julie Mussard; Christophe Caux; Nathalie Bendriss-Vermare; Philippe Pierre; Evelina Gatti
Journal:  Nat Commun       Date:  2017-10-13       Impact factor: 14.919

4.  Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection.

Authors:  Elena Tomasello; Karima Naciri; Rabie Chelbi; Gilles Bessou; Anissa Fries; Elise Gressier; Abdenour Abbas; Emeline Pollet; Philippe Pierre; Toby Lawrence; Thien-Phong Vu Manh; Marc Dalod
Journal:  EMBO J       Date:  2018-08-21       Impact factor: 11.598

Review 5.  Below the surface: The inner lives of TLR4 and TLR9.

Authors:  Laura Marongiu; Laura Gornati; Irene Artuso; Ivan Zanoni; Francesca Granucci
Journal:  J Leukoc Biol       Date:  2019-03-22       Impact factor: 4.962

Review 6.  Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.

Authors:  Pamela Velázquez-Díaz; Erika Nakajima; Parand Sorkhdini; Ashley Hernandez-Gutierrez; Adam Eberle; Dongqin Yang; Yang Zhou
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

Review 7.  Lysosomes and lysosome-related organelles in immune responses.

Authors:  Colin Watts
Journal:  FEBS Open Bio       Date:  2022-03-29       Impact factor: 2.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.